Data Report

Covid19 => Covid Treatments => Topic started by: Data Report on November 16, 2022, 10:32:55 pm

Title: Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print.
Post by: Data Report on November 16, 2022, 10:32:55 pm

Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print.

https://finance.yahoo.com/news/bioxytran-releases-positive-top-line-120000424.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAALYjVS13At1aFyi2T5pMKB9fQDH7Ag3h5oLZJLuOgqSlAvxGaRTf74vuNi8bNc1OhxZWrDZnV6FIxx7b3OweisYbZsrA-bpwsiZwuP0JhkCfhjfsClc3__Wk9lTzROMALkuSNB_7hDMlYrPef10pdPocEPHPiPRK0YHD5zQaf-YM